MAPT
Maptelligent, Inc.
Set alert
- YTD
- +233.33%
- 1 year
- +233.33%
- Open
- 0.0005
- Prev close
- 0.001
- Mkt cap
- 2.50M
- Vol
- 10.00K
- Avg vol
- 5
- EPS
- 0.02
- P/E
- 0.05
More statistics
- Low
- 0.0005
- High
- 0.0005
News
2 weeks ago seekingalpha.com
Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform
Arrowhead Pharmaceuticals, Inc. exceeded expectations with ARO-MAPT phase 1 results, achieving up to 85% CSF tau reduction and validating its subcutaneous CNS siRNA platform. ARWR plans to expand its…
2 weeks ago businesswire.com
Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from an ongoing Phase 1/2a study of ARO-MAPT, the company's investigational RNA…
1 month ago businesswire.com
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host an R&D webinar on Wednesday, October 14, 2026, at 11:30 AM PDT that will…
3 months ago gurufocus.com
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranerse
10 months ago businesswire.com
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the…
1 year ago businesswire.com
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical…
3 years ago globenewswire.com
Maptelligent, Inc., is Pleased to Announce it has Entered Into an Agreement With Axim Geospatial
LAS VEGAS, NV, Dec. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com – Axim Geospatial is to provide Maptelligent complete GIS services with…
4 years ago globenewswire.com
Maptelligent is Pleased to Announce Its New Strategic Focus, Implementing the Latest in Location Intelligence Making Indoor Maps More Intelligent
LAS VEGAS, NV, Feb. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com, its where indoor maps become intelligent. Maptelligent, Inc., has a new…
4 years ago globenewswire.com
Maptelligent, Inc., is Pleased to Announce a Partnership with Michael Quan with the Interactive Tactical Group
LAS VEGAS, NV, Nov. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc. (OTC PK: MAPT), www.maptelligent.com.
5 years ago globenewswire.com
NSION Technologies & Maptelligent Strategic Partnership
LAS VEGAS, NV, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc., (MAPT) has partnered with NSION Technologies to provide secure and enhanced situational awareness using real…
5 years ago globenewswire.com
Maptelligent, Inc., is Pleased to Announce Its New Management Services Agreement With Mr. Christopher Oudegeest, the Founder of Asbuilt Conditions
LAS VEGAS, NV, Sept. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com :
5 years ago globenewswire.com
Maptelligent, Inc. is Pleased to Announce Its New Strategic Partnership With the Award-winning Kant Consulting Group
LAS VEGAS, NV, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) www.maptelligent.com:
5 years ago globenewswire.com
Maptelligent, Inc. Announces Mr. Joel Rothschild as Chief Technical Officer
LAS VEGAS, NV, July 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) is pleased to announce that Mr. Joel Rothschild has joined Maptelligent, Inc., as its Chief…
5 years ago globenewswire.com
Maptelligent, Inc., Rebranding Efforts With the Launch of a New Website
LAS VEGAS, NV, June 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) www.maptelligent.com :
5 years ago globenewswire.com
Maptelligent, Inc., Solution Innovation
Las Vegas, Nevada, June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc., (OTCPK:MAPT), (www.maptelligent.com) is a company which provides indoor mapping capabilities for facility…
5 years ago globenewswire.com
Maptelligent, Inc., Executes an Agreement With GeoComm, Inc.
Las Vegas, NV, April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTCPK: MAPT) is pleased to announce, our recent agreement with GeoComm, the leading provider of Public Safety…
5 years ago globenewswire.com
UPDATE -- Maptelligent, Inc. Announces Mr. Eric Kant of Kant Consulting Group, LLC as a Consultant
LAS VEGAS, NV, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT), is pleased to announce, the official engagement as a consultant with Mr. Eric H. Kant the…